Top Companies in the Patient Registry Software

The global patient registry software market is projected to reach USD 3.61 billion by 2030 from USD 2.25 billion in 2025, at a CAGR of 9.8% during this forecast period. Several key factors are driving the demand for standardized patient registry tools, particularly the growing volume of clinical trials in fields such as oncology, cardiology, and rare diseases. These tools facilitate efficient patient recruitment, enable real-time data capture, and support post-marketing safety studies.

Additionally, advancements in technology, including AI-powered analytics, cloud integration, and interoperability with electronic health record (EHR) systems, are significantly enhancing the functionality and scalability of registry platforms. The global trend toward healthcare digitization, along with increased investments in health IT infrastructure—especially in emerging economies—is accelerating the adoption of patient registry software across healthcare provider networks, research institutions, and regulatory bodies.

To know about the assumptions considered for the study download the pdf brochure

Prominent players in the patient registry software market include IBM (US), IQVIA Holdings Inc. (US), Health Catalyst Inc. (US), Oracle (US), UnitedHealth Group (US), Conduent Inc. (US), and Elekta (Sweden), among others. These companies have adopted various strategies to strengthen their market presence, such as product launches, expansions, agreements, partnerships, collaborations, and acquisitions.

1. In October 2023, IQVIA Holdings Inc. (US) acquired OpenApp (Ireland), enhancing its capabilities in data-driven healthcare solutions and customized registry development for complex industry needs.
2. In November 2024, Health Catalyst (US) signed an agreement to acquire Intraprise Health (US), a cybersecurity provider that offers risk management platforms and services to protect clients from cyberattacks. This deal was expected to close in the fourth quarter of 2024.

IBM (US) has established a strong presence in the global patient registry software market due to its advanced healthcare data management solutions. Its flagship platform, InfoSphere Master Data Management (MDM) for Healthcare, is widely adopted for managing patient and provider information across complex healthcare ecosystems. The platform supports data standardization, governance, and interoperability, which are essential for building reliable and scalable patient registries. Recently, IBM enhanced the platform with version 14.0, which introduced improved compliance features, real-time data integration, and advanced analytics capabilities. These updates cater to the needs of value-based care and population health programs. IBM’s partnerships with hospitals, government agencies, and private payers around the world, along with its presence in 175 countries, reinforce its role as a digital backbone in healthcare transformation. The solutions provided by IBM enable healthcare stakeholders to streamline patient identity resolution, enhance care coordination, and derive insights for clinical research and policymaking.

IQVIA Holdings Inc. (US) is a leading provider of clinical and real-world data solutions, driving innovation in the patient registry software market with its integrated platforms and extensive expertise in life sciences. The company offers two main products: Patient Registry Solutions and the Clinical Insight Platform. These tools are designed to leverage real-world data for clinical trials, epidemiological studies, and long-term disease surveillance. IQVIA’s registries support both patient-reported and clinician-reported outcomes, which enhance research quality and ensure regulatory compliance. The platforms are highly customizable, compliant with GDPR, and capable of supporting multinational studies with diverse datasets. Recent strategic moves, such as the acquisition of OpenApp, have expanded IQVIA’s capabilities in developing registries for rare and chronic disease areas. Additionally, the company has partnered with Alibaba Cloud to deliver solutions in China, reinforcing its commitment to strengthening its presence in emerging markets. With operations in over 100 countries and strong connections to pharmaceutical, medical technology, and public health entities, IQVIA’s patient registry offerings play a crucial role in accelerating evidence generation, optimizing treatment, and improving health system performance.

Market Ranking

The ranking of companies in the patient registry software market was established through market share analysis, incorporating secondary research and primary validation. Key parameters included revenue from product offerings, innovation, brand recognition, and regional presence. The leading players are IBM, IQVIA Holdings Inc., Health Catalyst Inc., Oracle, and UnitedHealth Group.

IBM leads the market with its strong global presence and advanced data integration capabilities, notably through InfoSphere Master Data Management. IQVIA thrives on real-world data-powered registries like Clinical Insight and strategic acquisitions like OpenApp. Health Catalyst utilizes its cloud-based analytics platform and recently expanded its oncology registry offerings with the acquisition of ERS. Oracle offers interoperable registry solutions through its robust cloud infrastructure, while UnitedHealth Group uses patient registries for population health analytics via its Optum segment, leveraging extensive claims and EHR data. Other players include regional vendors and startups focused on niche registries and innovative solutions.

Related Reports:

Patient Registry Software Market by Disease (Diabetes, Cancer, Rare, Asthma, Kidney), Product (Drugs, Device), Use Case (Population Health, Research), End User [(Profit: Pharma, Payer, Hospital), (Non-Profit: Govt)] & Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com